Concepedia

Author

Mirte Scherpenisse

National Institute for Public Health and the Environment

Also Known As

M Scherpenisse, M. Scherpenisse, MIRTE SCHERPENISSE, Mirte Scherpenisse, Scherpenisse, Mirte

19

Publications

536

Citations

13

H-Index

20

Concepts

All Affiliations

National Institute for Public Health and the EnvironmentAmsterdam UMC Location Vrije Universiteit AmsterdamAmsterdam UMC Location University of AmsterdamUniversity of Amsterdam
MS

About

Mirte Scherpenisse is an author at National Institute for Public Health and the Environment specializing in epidemiology, human papillomavirus vaccines, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

165

2

Epidemiology

4

4

165

3

Public Health

2

2

83

4

Immunology

1

1

48

5

Obstetrics

1

1

31

Mirte Scherpenisse

×

11

Publications

463

Citations

11

H-Index

YearCitations

Characteristics of HPV-Specific Antibody Responses Induced by Infection and Vaccination: Cross-Reactivity, Neutralizing Activity, Avidity and IgG Subclasses

Mirte Scherpenisse, Rutger M. Schepp, Madelief Mollers,

PLoS ONE

2013

76

Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study

Marloes W Heijstek, Mirte Scherpenisse, Noortje Groot,

Annals of the Rheumatic Diseases

2013

76

Seroprevalence of seven high-risk HPV types in The Netherlands

Mirte Scherpenisse, Madelief Mollers, Rutger M. Schepp,

Vaccine

2012

51

Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination

Mirte Scherpenisse, Madelief Mollers, Rutger M. Schepp,

Human Vaccines & Immunotherapeutics

2013

48

Patterns of Human Papillomavirus DNA and Antibody Positivity in Young Males and Females, Suggesting a Site-Specific Natural Course of Infection

Henrike J. Vriend, Johannes A. Bogaards, Fiona van der Klis,

PLoS ONE

2013

45

Proceedings of the Frontiers of Retrovirology Conference 2016

Irena Zurnic, Sylvia Hütter, Ute Lehmann,

Retrovirology

2016

37

Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study

Madelief Mollers, Audrey J. King, Mirjam J. Knol,

Vaccine

2015

35

Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination

Madelief Mollers, Mirte Scherpenisse, Fiona van der Klis,

Cancer Epidemiology

2012

31

Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy

Mirte Scherpenisse, Neeltje A. Kootstra, Margreet Bakker,

mBio

2021

27

Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995–96 and 2006–07 in The Netherlands

Mirte Scherpenisse, Madelief Mollers, Rutger M. Schepp,

PLoS ONE

2012

19

Page 1